SCHEMBL6203954

SCHEMBL6203954

CCCCCCCOc1nc(CC)c(-c2ccc(C(C)C)cc2OC)nc1CC

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 15/20 0.44
CASR P41180 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203563 1.00 CRHR1 (0.44) CRHR1CASR
SCHEMBL6202927 0.99 CRHR1 (0.45) CRHR1CASR
SCHEMBL6201091 0.84 CRHR1 (0.43) CRHR1
SCHEMBL7475717 0.84 CRHR1 (0.60) CRHR1
SCHEMBL6204481 0.83 CRHR1 (0.45) CRHR1
SCHEMBL7482386 0.83 CRHR1 (0.42) CRHR1
SCHEMBL7470192 0.82 CRHR1 (0.59) CRHR1
SCHEMBL5438012 0.82 CRHR1 (0.59) CRHR1
SCHEMBL5434698 0.81 CRHR1 (0.50) CRHR1
SCHEMBL6200122 0.81 CRHR1 (0.47) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554258-A1 5-SUBSTITUTED-2-ARYLPYRAZINES AS MODULATORS OF CRF RECEPTORS NEUROGEN CORPORATION (US) 2005-07-20 EP claimed
WO-2004018437-A1 5-SUBSTITUTED-2-ARYLPYRAZINES AS MODULATORS OF CRF RECEPTORS NEUROGEN CORPORATION (US) 2004-03-04 WO claimed